These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14282070)

  • 1. THERMOSTABLE ANTICOAGULANT FROM THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Br J Haematol; 1965 May; 11():331-41. PubMed ID: 14282070
    [No Abstract]   [Full Text] [Related]  

  • 2. VARIABILITY OF THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Am J Physiol; 1965 Mar; 208():521-7. PubMed ID: 14264744
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDY OF FIBRINOGEN TURNOVER RATES AFTER TOTAL HEPATECTOMY IN DOGS.
    GANS H
    Surgery; 1964 Apr; 55():544-50. PubMed ID: 14138019
    [No Abstract]   [Full Text] [Related]  

  • 4. ISOLATION AND PROPERTIES OF ANTICOAGULANTS FROM FIBRINOLYSED AND HUMAN HEART-PUMP PLASMAS.
    TRIANTAPHYLLOPOULOS DC; TRIANTAPHYLLOPOULOS E
    Can J Physiol Pharmacol; 1964 Mar; 42():169-87. PubMed ID: 14329312
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 6. A COAGULATION ANOMALY: PLASMA BEING MADE NON-CLOTTABLE BY ADDING THROMBIN, AND CLOTTABLE BY THROMBOPLASTIN-CALCIUM OR TOLUIDINE BLUE-THROMBIN.V5 BLUE-THROMBIN.
    MAKI M; KIKUCHI K; WATANABE S; KIKUCHI E
    Tohoku J Exp Med; 1964 Dec; 84():274-81. PubMed ID: 14244484
    [No Abstract]   [Full Text] [Related]  

  • 7. Variable and invarible components of the anticoagulant fraction of incubated fibrinogen.
    Triantaphyllopoulos E; Triantaphyllopoulos DC
    Nature; 1966 Jan; 209(5020):265-7. PubMed ID: 5915958
    [No Abstract]   [Full Text] [Related]  

  • 8. [ELEVATION OF THE DEPRESSED THROMBOLYTIC ACTIVITY, IN ARTERIOSCLEROTICS SUBJECTED TO PROLONGED ORAL ANTICOAGULANT THERAPY, USING A DERIVATIVE OF NICOTINIC ACID].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1793-8. PubMed ID: 14165315
    [No Abstract]   [Full Text] [Related]  

  • 9. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 10. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 11. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES.
    ANDERSON AJ
    Biochem J; 1963 Sep; 88(3):460-9. PubMed ID: 14071519
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 13. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 14. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    SWEENEY WM
    Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294
    [No Abstract]   [Full Text] [Related]  

  • 15. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW; NILSSON IM
    Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840
    [No Abstract]   [Full Text] [Related]  

  • 16. [EXPERIMENT WITH A PLASMIN PREPARATION BY USING THE CASIN SPLITTING TEST: THE ACTION OF PLASMIN-NOVO AND ITS INHIBITION WITH EPSILON-AMINOCAPROIC ACID AND TRASYLOL].
    BERGHOFF A; GLATZEL H
    Thromb Diath Haemorrh; 1964 Dec; 12():418-24. PubMed ID: 14254701
    [No Abstract]   [Full Text] [Related]  

  • 17. THE ROLE OF FIBRINOLYSIN AND PROFIBRINOLYSIN ACTIVATOR IN HEMOPHILIA.
    REID WO; HOLBURN RR; DESIPIN MT; TOCANTINS LM
    Am J Med Sci; 1965 May; 249():518-33. PubMed ID: 14280891
    [No Abstract]   [Full Text] [Related]  

  • 18. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES ON THE TISSUE ACTIVATOR OF PLASMINOGEN. DISTRIBUTION OF ACTIVATOR AND PROTEOLYTIC ACTIVITY IN THE SUBCELLULAR FRACTIONS OF RABBIT KIDNEY.
    ALI SY; LACK CH
    Biochem J; 1965 Jul; 96(1):63-74. PubMed ID: 14343153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F; KLOECKING HP; RICHTER M
    Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.